A. Baasner

Cloning of a human parvovirus by molecular screening of respiratory tract samples

Down-Regulation of Na⁺/K⁺ATPase Activity by Human Parvovirus B19 Capsid Protein VP1

Adverse effects of immune-checkpoint inhibitors: epidemiology, management and surveillance

Quantitative Analyses of SMN1 and SMN2 Based on Real-Time LightCycler PCR: Fast and Highly Reliable Carrier Testing and Prediction of Severity of Spinal Muscular Atrophy

Advances of capillary electrophoresis in clinical and forensic analysis (1999-2000)

Prevalence of Muscular Dystrophies: A Systematic Literature Review

Treatment of infantile-onset spinal muscular atrophy with nusinersen: a phase 2, open-label, dose-escalation study

Identification of Proximal Spinal Muscular Atrophy Carriers and Patients by Analysis of SMNT and SMNC Gene Copy Number

An ~140-kb deletion associated with feline spinal muscular atrophy implies an essentialLIX1function for motor neuron survival

Spinal Muscular Atrophy: From Gene to Therapy

An update of the mutation spectrum of the survival motor neuron gene (SMN1) in autosomal recessive spinal muscular atrophy (SMA)

Genomic Rearrangements and Gene Copy-Number Alterations as a Cause of Nervous System Disorders

The Noncoding RNA Revolution—Trashing Old Rules to Forge New Ones

Parvovirus B19

The evolution of gene expression levels in mammalian organs

Microfluidics: Fluid physics at the nanoliter scale

A General Mechanism for Network-Dosage Compensation in Gene Circuits

When Is a Deletion Not a Deletion? When It Is Converted

Fatal Myocarditis Following Treatment with the PD‐1 Inhibitor Nivolumab

Instrumentation for trace detection of high explosives

Mapping of the Spinal MuscularAtrophy (SMA) Gene to a 750-kbInterval Flanked by Two NewMicrosatellites

Mildly affected patients with spinal muscular atrophy are partially protected by an increased SMN2 copy number

Mitochondrial DNA in the central european population

Fatal Parvovirus B19 Myocarditis in an 8-Year-Old Boy